CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development
- Autores
- Macias, Everardo; Miliani De Marval, Paula L.; de Siervi, Adriana; Conti, Claudio J.; Senderowicz, Adrian M.; Rodriguez Puebla, Marcelo L.
- Año de publicación
- 2008
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- It has been widely assumed that elevated CDK2 kinase activity plays a contributory role in tumorigenesis. We have previously shown that mice overexpressing CDK4 under control of the keratin 5 promoter (K5CDK4 mice) develop epidermal hyperplasia and increased susceptibility to squamous cell carcinomas. In this model, CDK4 overexpression results in increased CDK2 activity associated with the noncatalytic function of CDK4, sequestration of p21Cip1 and p27Kip1. Furthermore, we have shown that ablation of Cdk2 reduces Ras-Cdk4 tumorigenesis, suggesting that increased CDK2 activity plays an important role in Ras-mediated tumorigenesis. To investigate this hypothesis, we generated two transgenic mouse models of elevated CDK2 kinase activity, K5Cdk2 and K5Cdk4D158N mice. The D158N mutation blocks CDK4 kinase activity without interfering with its binding capability. CDK2 activation via overexpression of CDK4D158N, but not of CDK2, resulted in epidermal hyperplasia. We observed elevated levels of p21 Cip1 in K5Cdk2, but not in K5Cdk4D158N, epidermis, suggesting that CDK2 overexpression elicits a p21Cip1 response to maintain keratinocyte homeostasis. Surprisingly, we found that neither CDK2 overexpression nor the indirect activation of CDK2 enhanced skin tumor development. Thus, although the indirect activation of CDK2 is sufficient to induce keratinocyte hyperproliferation, activation of CDK2 alone does not induce malignant progression in Ras-mediated tumorigenesis. Copyright © American Society for Investigative Pathology.
Fil: Macias, Everardo. North Carolina State University; Estados Unidos
Fil: Miliani De Marval, Paula L.. Duke University Medical Center; Estados Unidos
Fil: de Siervi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. National Institutes of Health; Estados Unidos
Fil: Conti, Claudio J.. the M.D. Anderson Cancer Center; Estados Unidos
Fil: Senderowicz, Adrian M.. National Institutes of Health; Estados Unidos. United States Food and Drug Administration; Estados Unidos
Fil: Rodriguez Puebla, Marcelo L.. North Carolina State University; Estados Unidos - Materia
-
CDK2
Transgenic mice - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/71282
Ver los metadatos del registro completo
id |
CONICETDig_9a6e25062be670a015401d62e4b13430 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/71282 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor developmentMacias, EverardoMiliani De Marval, Paula L.de Siervi, AdrianaConti, Claudio J.Senderowicz, Adrian M.Rodriguez Puebla, Marcelo L.CDK2Transgenic micehttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1It has been widely assumed that elevated CDK2 kinase activity plays a contributory role in tumorigenesis. We have previously shown that mice overexpressing CDK4 under control of the keratin 5 promoter (K5CDK4 mice) develop epidermal hyperplasia and increased susceptibility to squamous cell carcinomas. In this model, CDK4 overexpression results in increased CDK2 activity associated with the noncatalytic function of CDK4, sequestration of p21Cip1 and p27Kip1. Furthermore, we have shown that ablation of Cdk2 reduces Ras-Cdk4 tumorigenesis, suggesting that increased CDK2 activity plays an important role in Ras-mediated tumorigenesis. To investigate this hypothesis, we generated two transgenic mouse models of elevated CDK2 kinase activity, K5Cdk2 and K5Cdk4D158N mice. The D158N mutation blocks CDK4 kinase activity without interfering with its binding capability. CDK2 activation via overexpression of CDK4D158N, but not of CDK2, resulted in epidermal hyperplasia. We observed elevated levels of p21 Cip1 in K5Cdk2, but not in K5Cdk4D158N, epidermis, suggesting that CDK2 overexpression elicits a p21Cip1 response to maintain keratinocyte homeostasis. Surprisingly, we found that neither CDK2 overexpression nor the indirect activation of CDK2 enhanced skin tumor development. Thus, although the indirect activation of CDK2 is sufficient to induce keratinocyte hyperproliferation, activation of CDK2 alone does not induce malignant progression in Ras-mediated tumorigenesis. Copyright © American Society for Investigative Pathology.Fil: Macias, Everardo. North Carolina State University; Estados UnidosFil: Miliani De Marval, Paula L.. Duke University Medical Center; Estados UnidosFil: de Siervi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. National Institutes of Health; Estados UnidosFil: Conti, Claudio J.. the M.D. Anderson Cancer Center; Estados UnidosFil: Senderowicz, Adrian M.. National Institutes of Health; Estados Unidos. United States Food and Drug Administration; Estados UnidosFil: Rodriguez Puebla, Marcelo L.. North Carolina State University; Estados UnidosAmerican Society of Investigative Pathology2008-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/71282Macias, Everardo; Miliani De Marval, Paula L.; de Siervi, Adriana; Conti, Claudio J.; Senderowicz, Adrian M.; et al.; CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development; American Society of Investigative Pathology; American Journal Of Pathology; 173; 2; 12-2008; 526-5350002-9440CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.2353/ajpath.2008.071124info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0002944010616288info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:39:12Zoai:ri.conicet.gov.ar:11336/71282instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:39:13.008CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development |
title |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development |
spellingShingle |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development Macias, Everardo CDK2 Transgenic mice |
title_short |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development |
title_full |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development |
title_fullStr |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development |
title_full_unstemmed |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development |
title_sort |
CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development |
dc.creator.none.fl_str_mv |
Macias, Everardo Miliani De Marval, Paula L. de Siervi, Adriana Conti, Claudio J. Senderowicz, Adrian M. Rodriguez Puebla, Marcelo L. |
author |
Macias, Everardo |
author_facet |
Macias, Everardo Miliani De Marval, Paula L. de Siervi, Adriana Conti, Claudio J. Senderowicz, Adrian M. Rodriguez Puebla, Marcelo L. |
author_role |
author |
author2 |
Miliani De Marval, Paula L. de Siervi, Adriana Conti, Claudio J. Senderowicz, Adrian M. Rodriguez Puebla, Marcelo L. |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
CDK2 Transgenic mice |
topic |
CDK2 Transgenic mice |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
It has been widely assumed that elevated CDK2 kinase activity plays a contributory role in tumorigenesis. We have previously shown that mice overexpressing CDK4 under control of the keratin 5 promoter (K5CDK4 mice) develop epidermal hyperplasia and increased susceptibility to squamous cell carcinomas. In this model, CDK4 overexpression results in increased CDK2 activity associated with the noncatalytic function of CDK4, sequestration of p21Cip1 and p27Kip1. Furthermore, we have shown that ablation of Cdk2 reduces Ras-Cdk4 tumorigenesis, suggesting that increased CDK2 activity plays an important role in Ras-mediated tumorigenesis. To investigate this hypothesis, we generated two transgenic mouse models of elevated CDK2 kinase activity, K5Cdk2 and K5Cdk4D158N mice. The D158N mutation blocks CDK4 kinase activity without interfering with its binding capability. CDK2 activation via overexpression of CDK4D158N, but not of CDK2, resulted in epidermal hyperplasia. We observed elevated levels of p21 Cip1 in K5Cdk2, but not in K5Cdk4D158N, epidermis, suggesting that CDK2 overexpression elicits a p21Cip1 response to maintain keratinocyte homeostasis. Surprisingly, we found that neither CDK2 overexpression nor the indirect activation of CDK2 enhanced skin tumor development. Thus, although the indirect activation of CDK2 is sufficient to induce keratinocyte hyperproliferation, activation of CDK2 alone does not induce malignant progression in Ras-mediated tumorigenesis. Copyright © American Society for Investigative Pathology. Fil: Macias, Everardo. North Carolina State University; Estados Unidos Fil: Miliani De Marval, Paula L.. Duke University Medical Center; Estados Unidos Fil: de Siervi, Adriana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. National Institutes of Health; Estados Unidos Fil: Conti, Claudio J.. the M.D. Anderson Cancer Center; Estados Unidos Fil: Senderowicz, Adrian M.. National Institutes of Health; Estados Unidos. United States Food and Drug Administration; Estados Unidos Fil: Rodriguez Puebla, Marcelo L.. North Carolina State University; Estados Unidos |
description |
It has been widely assumed that elevated CDK2 kinase activity plays a contributory role in tumorigenesis. We have previously shown that mice overexpressing CDK4 under control of the keratin 5 promoter (K5CDK4 mice) develop epidermal hyperplasia and increased susceptibility to squamous cell carcinomas. In this model, CDK4 overexpression results in increased CDK2 activity associated with the noncatalytic function of CDK4, sequestration of p21Cip1 and p27Kip1. Furthermore, we have shown that ablation of Cdk2 reduces Ras-Cdk4 tumorigenesis, suggesting that increased CDK2 activity plays an important role in Ras-mediated tumorigenesis. To investigate this hypothesis, we generated two transgenic mouse models of elevated CDK2 kinase activity, K5Cdk2 and K5Cdk4D158N mice. The D158N mutation blocks CDK4 kinase activity without interfering with its binding capability. CDK2 activation via overexpression of CDK4D158N, but not of CDK2, resulted in epidermal hyperplasia. We observed elevated levels of p21 Cip1 in K5Cdk2, but not in K5Cdk4D158N, epidermis, suggesting that CDK2 overexpression elicits a p21Cip1 response to maintain keratinocyte homeostasis. Surprisingly, we found that neither CDK2 overexpression nor the indirect activation of CDK2 enhanced skin tumor development. Thus, although the indirect activation of CDK2 is sufficient to induce keratinocyte hyperproliferation, activation of CDK2 alone does not induce malignant progression in Ras-mediated tumorigenesis. Copyright © American Society for Investigative Pathology. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/71282 Macias, Everardo; Miliani De Marval, Paula L.; de Siervi, Adriana; Conti, Claudio J.; Senderowicz, Adrian M.; et al.; CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development; American Society of Investigative Pathology; American Journal Of Pathology; 173; 2; 12-2008; 526-535 0002-9440 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/71282 |
identifier_str_mv |
Macias, Everardo; Miliani De Marval, Paula L.; de Siervi, Adriana; Conti, Claudio J.; Senderowicz, Adrian M.; et al.; CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development; American Society of Investigative Pathology; American Journal Of Pathology; 173; 2; 12-2008; 526-535 0002-9440 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.2353/ajpath.2008.071124 info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0002944010616288 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Society of Investigative Pathology |
publisher.none.fl_str_mv |
American Society of Investigative Pathology |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613239981211648 |
score |
13.070432 |